OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Merck & Co Inc/  US58933Y1055  /

IEX
9/13/2024  9:59:58 PM Chg. +0.54 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
115.85USD +0.47% 186,624
Turnover: 21.6 mill.		 -Bid Size: - -Ask Size: - 293.68 bill.USD 2.55% 827.57
TeleTrader 7/30 Merck falls 7% after Q2 earnings report
TeleTrader 7/30 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 7/17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
GlobeNewswire 7/9 Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination ...
GlobeNewswire 6/27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 6/25 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...
GlobeNewswire 6/18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 6/5 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 6/3 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
TeleTrader 5/29 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 5/29 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 5/29 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/6 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 5/2 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/6 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 3/4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 2/2 Merck Group to expand investment in South Korea
TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 1/23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...